These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 8112145)
1. [Treatment of rapid progressive glomerulonephritis (RPGN) with pulse methylprednisolone (MP) and urokinase (UK): a renal rebiopsy study]. Chen XM; Cheng QL Zhonghua Nei Ke Za Zhi; 1993 Sep; 32(9):607-9. PubMed ID: 8112145 [TBL] [Abstract][Full Text] [Related]
2. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis. Tang Z; Zhou H; Yao X; Hu W; Leishi L Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342 [TBL] [Abstract][Full Text] [Related]
3. Methylprednisolone pulse therapy in rapidly progressive glomerulonephritis. de Glas-Vos JW; Krediet RT; Arisz L Neth J Med; 1991 Apr; 38(3-4):96-103. PubMed ID: 1881508 [TBL] [Abstract][Full Text] [Related]
4. Clinical and histologic response to methylprednisolone pulse therapy in glomerulonephritis. Cho BS; Park SS; Kim SD; Won KY; Lim SJ Fetal Pediatr Pathol; 2010; 29(4):271-90. PubMed ID: 20594152 [TBL] [Abstract][Full Text] [Related]
5. [Steroid pulse therapy in rapidly progressive glomerulonephritis]. Ogi M; Yoshimura M; Ikeda K; Saito Y; Kida H; Sugioka G; Watanabe K Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):669-75. PubMed ID: 1479706 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. Kawasaki Y; Suzuki J; Suzuki H Nephrol Dial Transplant; 2004 Apr; 19(4):858-64. PubMed ID: 15031341 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of rapidly progressive glomerulonephritis. An analysis of 20 cases]. Cheng HF; Wang HY; Pan JS Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):222-5, 254. PubMed ID: 1874090 [TBL] [Abstract][Full Text] [Related]
9. [A clinicopathological study of patients with immune complex type and pauci immune type rapidly progressive glomerulonephritis]. Sugiyama H; Makino H; Wada J; Ota K; Nagake Y; Morioka S; Yamasaki Y; Shikata K; Kashihara N; Ikeda S Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):777-82. PubMed ID: 8377291 [TBL] [Abstract][Full Text] [Related]
10. [Changes in coagulation and fibrinolytic factors observed during heparin-urokinase-pulse combined therapy for nephritis resistant to conventional treatment in children]. Koitabashi Y; Ikoma M; Shibawaka T; Yamaguchi Y; Mio H; Doi K; Meguro T; Yamada K Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1155-61. PubMed ID: 7505345 [TBL] [Abstract][Full Text] [Related]
11. [Effects of methylprednisolone pulse therapy in the insidious type of crescentic glomerulonephritis]. Takeda S; Kida H; Takazakura E; Yokoyama H; Kobayashi K Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):490-6. PubMed ID: 9379560 [TBL] [Abstract][Full Text] [Related]
12. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis. Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629 [TBL] [Abstract][Full Text] [Related]
13. [Laboratory and morphologic parameters in patients with lupus nephritis]. Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312 [TBL] [Abstract][Full Text] [Related]
14. Crescentic lupus glomerulonephritis. Yeung CK; Wong KL; Wong WS; Ng MT; Chan KW; Ng WL Clin Nephrol; 1984 May; 21(5):251-8. PubMed ID: 6733993 [TBL] [Abstract][Full Text] [Related]
15. [Effect of methylprednisolone pulse therapy in patients with lupus nephritis assessed by WHO morphologic classification]. Makino H; Yamasaki Y; Hayashi Y; Haramoto T; Shikata K; Kumagai I; Taniai K; Takahashi K; Ota Z Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):791-9. PubMed ID: 2273595 [TBL] [Abstract][Full Text] [Related]
16. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482 [TBL] [Abstract][Full Text] [Related]
17. Progression of membranous nephropathy to acute crescentic rapidly progressive glomerulonephritis and response to pulse methylprednisolone. Koethe JD; Gerig JS; Glickman JL; Sturgill BC; Bolton WK Am J Nephrol; 1986; 6(3):224-8. PubMed ID: 3740132 [TBL] [Abstract][Full Text] [Related]
18. Pathological spectrums and renal prognosis of severe lupus patients with rapidly progressive glomerulonephritis. Chen S; Chen H; Liu Z; Zhang H; Hu W; Tang Z; Liu Z Rheumatol Int; 2015 Apr; 35(4):709-17. PubMed ID: 25281226 [TBL] [Abstract][Full Text] [Related]
19. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH; Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070 [TBL] [Abstract][Full Text] [Related]
20. Aggressive treatment with pulse methylprednisolone or plasma exchange is justified in rapidly progressive glomerulonephritis. Stevens ME; McConnell M; Bone JM Proc Eur Dial Transplant Assoc; 1983; 19():724-31. PubMed ID: 6878261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]